T 0860/16 (Sublingual immunotherapy/ALK-ABELLÓ) of 12.11.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T086016.20191112
- Date of decision
- 12 November 2019
- Case number
- T 0860/16
- Online on
- 2 October 2020
- Petition for review of
- -
- Application number
- 09730293.9
- IPC class
- A61K 39/35A61K 39/36
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
- Applicant name
- ALK-Abelló A/S
- Opponent name
- Merck Patent GmbH
Leeming, John Gerard
Stallergenes - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)
- Keywords
- Main (sole) request - inventive step (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.